nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0938	0.166	CbGbCtD
Acetylcysteine—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0848	0.15	CbGbCtD
Acetylcysteine—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0782	0.139	CbGbCtD
Acetylcysteine—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0691	0.123	CbGbCtD
Acetylcysteine—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0545	0.0968	CbGbCtD
Acetylcysteine—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0486	0.0862	CbGbCtD
Acetylcysteine—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0413	0.0733	CbGbCtD
Acetylcysteine—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0397	0.0705	CbGbCtD
Acetylcysteine—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0279	0.0495	CbGbCtD
Acetylcysteine—SLC22A6—Losartan—type 2 diabetes mellitus	0.0255	0.0453	CbGbCtD
Acetylcysteine—SLC7A11—forelimb zeugopod—type 2 diabetes mellitus	0.0169	0.267	CbGeAlD
Acetylcysteine—GRIN2B—nerve—type 2 diabetes mellitus	0.00491	0.0778	CbGeAlD
Acetylcysteine—GRIN2A—nerve—type 2 diabetes mellitus	0.00429	0.068	CbGeAlD
Acetylcysteine—L-Cysteine—CDO1—type 2 diabetes mellitus	0.00311	0.608	CrCbGaD
Acetylcysteine—ACY1—kidney—type 2 diabetes mellitus	0.0028	0.0443	CbGeAlD
Acetylcysteine—SLC7A11—islet of Langerhans—type 2 diabetes mellitus	0.00225	0.0356	CbGeAlD
Acetylcysteine—L-Cysteine—CBS—type 2 diabetes mellitus	0.002	0.392	CrCbGaD
Acetylcysteine—CHUK—cardiovascular system—type 2 diabetes mellitus	0.00197	0.0312	CbGeAlD
Acetylcysteine—GSS—islet of Langerhans—type 2 diabetes mellitus	0.00182	0.0288	CbGeAlD
Acetylcysteine—ACY1—liver—type 2 diabetes mellitus	0.00177	0.028	CbGeAlD
Acetylcysteine—CHUK—adipose tissue—type 2 diabetes mellitus	0.00174	0.0276	CbGeAlD
Acetylcysteine—SLC7A11—kidney—type 2 diabetes mellitus	0.00159	0.0252	CbGeAlD
Acetylcysteine—SLC7A11—pancreas—type 2 diabetes mellitus	0.00158	0.025	CbGeAlD
Acetylcysteine—GSS—retina—type 2 diabetes mellitus	0.00156	0.0246	CbGeAlD
Acetylcysteine—GSS—nephron tubule—type 2 diabetes mellitus	0.00147	0.0232	CbGeAlD
Acetylcysteine—SLC7A11—adipose tissue—type 2 diabetes mellitus	0.00143	0.0227	CbGeAlD
Acetylcysteine—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.0014	0.0221	CbGeAlD
Acetylcysteine—IKBKB—cardiovascular system—type 2 diabetes mellitus	0.00134	0.0212	CbGeAlD
Acetylcysteine—GSS—cardiovascular system—type 2 diabetes mellitus	0.00132	0.0208	CbGeAlD
Acetylcysteine—GSS—kidney—type 2 diabetes mellitus	0.00129	0.0204	CbGeAlD
Acetylcysteine—GSS—pancreas—type 2 diabetes mellitus	0.00128	0.0203	CbGeAlD
Acetylcysteine—IKBKB—cortex of kidney—type 2 diabetes mellitus	0.00128	0.0202	CbGeAlD
Acetylcysteine—GSS—cortex of kidney—type 2 diabetes mellitus	0.00125	0.0199	CbGeAlD
Acetylcysteine—CHUK—liver—type 2 diabetes mellitus	0.00122	0.0193	CbGeAlD
Acetylcysteine—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.0012	0.019	CbGeAlD
Acetylcysteine—IKBKB—adipose tissue—type 2 diabetes mellitus	0.00118	0.0187	CbGeAlD
Acetylcysteine—GSS—adipose tissue—type 2 diabetes mellitus	0.00116	0.0184	CbGeAlD
Acetylcysteine—SLCO1B1—kidney—type 2 diabetes mellitus	0.000947	0.015	CbGeAlD
Acetylcysteine—IKBKB—liver—type 2 diabetes mellitus	0.000829	0.0131	CbGeAlD
Acetylcysteine—GSS—liver—type 2 diabetes mellitus	0.000814	0.0129	CbGeAlD
Acetylcysteine—SLCO1B1—liver—type 2 diabetes mellitus	0.000598	0.00948	CbGeAlD
Acetylcysteine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000353	0.00185	CcSEcCtD
Acetylcysteine—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000353	0.00185	CcSEcCtD
Acetylcysteine—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000352	0.00185	CcSEcCtD
Acetylcysteine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000352	0.00184	CcSEcCtD
Acetylcysteine—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000349	0.00183	CcSEcCtD
Acetylcysteine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000348	0.00182	CcSEcCtD
Acetylcysteine—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000347	0.00182	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000347	0.00182	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000347	0.00181	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000346	0.00181	CcSEcCtD
Acetylcysteine—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000343	0.0018	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000342	0.00179	CcSEcCtD
Acetylcysteine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000342	0.00179	CcSEcCtD
Acetylcysteine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000338	0.00177	CcSEcCtD
Acetylcysteine—Asthma—Ramipril—type 2 diabetes mellitus	0.000333	0.00174	CcSEcCtD
Acetylcysteine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000333	0.00174	CcSEcCtD
Acetylcysteine—Sweating—Losartan—type 2 diabetes mellitus	0.000332	0.00174	CcSEcCtD
Acetylcysteine—Oedema—Glyburide—type 2 diabetes mellitus	0.000331	0.00173	CcSEcCtD
Acetylcysteine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000331	0.00173	CcSEcCtD
Acetylcysteine—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000328	0.00172	CcSEcCtD
Acetylcysteine—Rash—Repaglinide—type 2 diabetes mellitus	0.000328	0.00172	CcSEcCtD
Acetylcysteine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000328	0.00172	CcSEcCtD
Acetylcysteine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000328	0.00172	CcSEcCtD
Acetylcysteine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000327	0.00171	CcSEcCtD
Acetylcysteine—Shock—Glyburide—type 2 diabetes mellitus	0.000326	0.00171	CcSEcCtD
Acetylcysteine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000325	0.0017	CcSEcCtD
Acetylcysteine—Flushing—Metformin—type 2 diabetes mellitus	0.000325	0.0017	CcSEcCtD
Acetylcysteine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000325	0.0017	CcSEcCtD
Acetylcysteine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00169	CcSEcCtD
Acetylcysteine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000322	0.00169	CcSEcCtD
Acetylcysteine—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00032	0.00168	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.00032	0.00168	CcSEcCtD
Acetylcysteine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000319	0.00167	CcSEcCtD
Acetylcysteine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000319	0.00167	CcSEcCtD
Acetylcysteine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000318	0.00167	CcSEcCtD
Acetylcysteine—Cough—Gliclazide—type 2 diabetes mellitus	0.000318	0.00166	CcSEcCtD
Acetylcysteine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000318	0.00166	CcSEcCtD
Acetylcysteine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000317	0.00166	CcSEcCtD
Acetylcysteine—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000316	0.00166	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000316	0.00165	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000313	0.00164	CcSEcCtD
Acetylcysteine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00031	0.00162	CcSEcCtD
Acetylcysteine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00031	0.00162	CcSEcCtD
Acetylcysteine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000309	0.00162	CcSEcCtD
Acetylcysteine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000309	0.00162	CcSEcCtD
Acetylcysteine—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000309	0.00162	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000308	0.00161	CcSEcCtD
Acetylcysteine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000307	0.00161	CcSEcCtD
Acetylcysteine—Flushing—Irbesartan—type 2 diabetes mellitus	0.000307	0.00161	CcSEcCtD
Acetylcysteine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000306	0.0016	CcSEcCtD
Acetylcysteine—Erythema—Metformin—type 2 diabetes mellitus	0.000305	0.0016	CcSEcCtD
Acetylcysteine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000304	0.00159	CcSEcCtD
Acetylcysteine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000304	0.00159	CcSEcCtD
Acetylcysteine—Angioedema—Orlistat—type 2 diabetes mellitus	0.000302	0.00158	CcSEcCtD
Acetylcysteine—Syncope—Valsartan—type 2 diabetes mellitus	0.0003	0.00157	CcSEcCtD
Acetylcysteine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.0003	0.00157	CcSEcCtD
Acetylcysteine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000298	0.00156	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000298	0.00156	CcSEcCtD
Acetylcysteine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000296	0.00155	CcSEcCtD
Acetylcysteine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000295	0.00155	CcSEcCtD
Acetylcysteine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000295	0.00154	CcSEcCtD
Acetylcysteine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000294	0.00154	CcSEcCtD
Acetylcysteine—Cough—Valsartan—type 2 diabetes mellitus	0.000292	0.00153	CcSEcCtD
Acetylcysteine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000292	0.00153	CcSEcCtD
Acetylcysteine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000291	0.00153	CcSEcCtD
Acetylcysteine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00029	0.00152	CcSEcCtD
Acetylcysteine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.00029	0.00152	CcSEcCtD
Acetylcysteine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000289	0.00151	CcSEcCtD
Acetylcysteine—Cough—Orlistat—type 2 diabetes mellitus	0.000289	0.00151	CcSEcCtD
Acetylcysteine—Flushing—Losartan—type 2 diabetes mellitus	0.000289	0.00151	CcSEcCtD
Acetylcysteine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000288	0.00151	CcSEcCtD
Acetylcysteine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000288	0.00151	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000287	0.00151	CcSEcCtD
Acetylcysteine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000286	0.0015	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000286	0.0015	CcSEcCtD
Acetylcysteine—Sweating—Ramipril—type 2 diabetes mellitus	0.000285	0.00149	CcSEcCtD
Acetylcysteine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000284	0.00149	CcSEcCtD
Acetylcysteine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000284	0.00149	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000283	0.00148	CcSEcCtD
Acetylcysteine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000282	0.00148	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00028	0.00146	CcSEcCtD
Acetylcysteine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000278	0.00146	CcSEcCtD
Acetylcysteine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000274	0.00143	CcSEcCtD
Acetylcysteine—Syncope—Metformin—type 2 diabetes mellitus	0.000273	0.00143	CcSEcCtD
Acetylcysteine—Oedema—Valsartan—type 2 diabetes mellitus	0.000273	0.00143	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000273	0.00143	CcSEcCtD
Acetylcysteine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000273	0.00143	CcSEcCtD
Acetylcysteine—Rash—Glipizide—type 2 diabetes mellitus	0.000271	0.00142	CcSEcCtD
Acetylcysteine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000271	0.00142	CcSEcCtD
Acetylcysteine—Erythema—Losartan—type 2 diabetes mellitus	0.000271	0.00142	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00027	0.00141	CcSEcCtD
Acetylcysteine—Oedema—Orlistat—type 2 diabetes mellitus	0.00027	0.00141	CcSEcCtD
Acetylcysteine—Shock—Valsartan—type 2 diabetes mellitus	0.000269	0.00141	CcSEcCtD
Acetylcysteine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000268	0.0014	CcSEcCtD
Acetylcysteine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000265	0.00139	CcSEcCtD
Acetylcysteine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000265	0.00139	CcSEcCtD
Acetylcysteine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000265	0.00139	CcSEcCtD
Acetylcysteine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000265	0.00139	CcSEcCtD
Acetylcysteine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000264	0.00138	CcSEcCtD
Acetylcysteine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000263	0.00138	CcSEcCtD
Acetylcysteine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000263	0.00138	CcSEcCtD
Acetylcysteine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000262	0.00137	CcSEcCtD
Acetylcysteine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000262	0.00137	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000261	0.00137	CcSEcCtD
Acetylcysteine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000258	0.00135	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000258	0.00135	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000257	0.00134	CcSEcCtD
Acetylcysteine—Nausea—Glipizide—type 2 diabetes mellitus	0.000256	0.00134	CcSEcCtD
Acetylcysteine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000255	0.00134	CcSEcCtD
Acetylcysteine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000255	0.00134	CcSEcCtD
Acetylcysteine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000254	0.00133	CcSEcCtD
Acetylcysteine—Rash—Glimepiride—type 2 diabetes mellitus	0.000253	0.00133	CcSEcCtD
Acetylcysteine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000253	0.00132	CcSEcCtD
Acetylcysteine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000253	0.00132	CcSEcCtD
Acetylcysteine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000252	0.00132	CcSEcCtD
Acetylcysteine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000252	0.00132	CcSEcCtD
Acetylcysteine—Cough—Irbesartan—type 2 diabetes mellitus	0.000251	0.00131	CcSEcCtD
Acetylcysteine—Oedema—Metformin—type 2 diabetes mellitus	0.000249	0.0013	CcSEcCtD
Acetylcysteine—Flushing—Ramipril—type 2 diabetes mellitus	0.000247	0.0013	CcSEcCtD
Acetylcysteine—Angioedema—Losartan—type 2 diabetes mellitus	0.000247	0.0013	CcSEcCtD
Acetylcysteine—Shock—Metformin—type 2 diabetes mellitus	0.000245	0.00128	CcSEcCtD
Acetylcysteine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000244	0.00128	CcSEcCtD
Acetylcysteine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000244	0.00128	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000243	0.00127	CcSEcCtD
Acetylcysteine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000243	0.00127	CcSEcCtD
Acetylcysteine—Syncope—Losartan—type 2 diabetes mellitus	0.000243	0.00127	CcSEcCtD
Acetylcysteine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000242	0.00127	CcSEcCtD
Acetylcysteine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000241	0.00126	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.00024	0.00126	CcSEcCtD
Acetylcysteine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00024	0.00126	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00024	0.00126	CcSEcCtD
Acetylcysteine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00125	CcSEcCtD
Acetylcysteine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000238	0.00125	CcSEcCtD
Acetylcysteine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000238	0.00125	CcSEcCtD
Acetylcysteine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000238	0.00125	CcSEcCtD
Acetylcysteine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000238	0.00124	CcSEcCtD
Acetylcysteine—Cough—Losartan—type 2 diabetes mellitus	0.000236	0.00124	CcSEcCtD
Acetylcysteine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000236	0.00124	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000236	0.00124	CcSEcCtD
Acetylcysteine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000235	0.00123	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000235	0.00123	CcSEcCtD
Acetylcysteine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000235	0.00123	CcSEcCtD
Acetylcysteine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000234	0.00123	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000233	0.00122	CcSEcCtD
Acetylcysteine—Hypotension—Metformin—type 2 diabetes mellitus	0.000232	0.00122	CcSEcCtD
Acetylcysteine—Erythema—Ramipril—type 2 diabetes mellitus	0.000232	0.00122	CcSEcCtD
Acetylcysteine—Shock—Irbesartan—type 2 diabetes mellitus	0.000231	0.00121	CcSEcCtD
Acetylcysteine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00023	0.00121	CcSEcCtD
Acetylcysteine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000229	0.0012	CcSEcCtD
Acetylcysteine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000228	0.0012	CcSEcCtD
Acetylcysteine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00119	CcSEcCtD
Acetylcysteine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000228	0.00119	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000227	0.00119	CcSEcCtD
Acetylcysteine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000222	0.00116	CcSEcCtD
Acetylcysteine—Somnolence—Metformin—type 2 diabetes mellitus	0.000221	0.00116	CcSEcCtD
Acetylcysteine—Oedema—Losartan—type 2 diabetes mellitus	0.000221	0.00116	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000221	0.00116	CcSEcCtD
Acetylcysteine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000219	0.00115	CcSEcCtD
Acetylcysteine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000219	0.00115	CcSEcCtD
Acetylcysteine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000219	0.00115	CcSEcCtD
Acetylcysteine—Shock—Losartan—type 2 diabetes mellitus	0.000217	0.00114	CcSEcCtD
Acetylcysteine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000217	0.00114	CcSEcCtD
Acetylcysteine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000216	0.00113	CcSEcCtD
Acetylcysteine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00113	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000215	0.00112	CcSEcCtD
Acetylcysteine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000214	0.00112	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000214	0.00112	CcSEcCtD
Acetylcysteine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000213	0.00112	CcSEcCtD
Acetylcysteine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000212	0.00111	CcSEcCtD
Acetylcysteine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000211	0.0011	CcSEcCtD
Acetylcysteine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00021	0.0011	CcSEcCtD
Acetylcysteine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000209	0.0011	CcSEcCtD
Acetylcysteine—Rash—Glyburide—type 2 diabetes mellitus	0.000209	0.00109	CcSEcCtD
Acetylcysteine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000209	0.00109	CcSEcCtD
Acetylcysteine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000209	0.00109	CcSEcCtD
Acetylcysteine—Syncope—Ramipril—type 2 diabetes mellitus	0.000208	0.00109	CcSEcCtD
Acetylcysteine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000207	0.00108	CcSEcCtD
Acetylcysteine—Hypotension—Losartan—type 2 diabetes mellitus	0.000206	0.00108	CcSEcCtD
Acetylcysteine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000204	0.00107	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000203	0.00106	CcSEcCtD
Acetylcysteine—Cough—Ramipril—type 2 diabetes mellitus	0.000203	0.00106	CcSEcCtD
Acetylcysteine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000201	0.00105	CcSEcCtD
Acetylcysteine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000199	0.00104	CcSEcCtD
Acetylcysteine—Urticaria—Metformin—type 2 diabetes mellitus	0.000198	0.00103	CcSEcCtD
Acetylcysteine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000197	0.00103	CcSEcCtD
Acetylcysteine—Nausea—Glyburide—type 2 diabetes mellitus	0.000197	0.00103	CcSEcCtD
Acetylcysteine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000197	0.00103	CcSEcCtD
Acetylcysteine—Somnolence—Losartan—type 2 diabetes mellitus	0.000196	0.00103	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000196	0.00103	CcSEcCtD
Acetylcysteine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000194	0.00102	CcSEcCtD
Acetylcysteine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000193	0.00101	CcSEcCtD
Acetylcysteine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000191	0.001	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000189	0.000992	CcSEcCtD
Acetylcysteine—Oedema—Ramipril—type 2 diabetes mellitus	0.000189	0.000992	CcSEcCtD
Acetylcysteine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000189	0.00099	CcSEcCtD
Acetylcysteine—Rash—Gliclazide—type 2 diabetes mellitus	0.000187	0.000982	CcSEcCtD
Acetylcysteine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000187	0.000981	CcSEcCtD
Acetylcysteine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000186	0.000977	CcSEcCtD
Acetylcysteine—Shock—Ramipril—type 2 diabetes mellitus	0.000186	0.000976	CcSEcCtD
Acetylcysteine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000186	0.000972	CcSEcCtD
Acetylcysteine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000185	0.000968	CcSEcCtD
Acetylcysteine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000184	0.000964	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000183	0.000959	CcSEcCtD
Acetylcysteine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000181	0.000946	CcSEcCtD
Acetylcysteine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000178	0.000935	CcSEcCtD
Acetylcysteine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000177	0.000927	CcSEcCtD
Acetylcysteine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000177	0.000925	CcSEcCtD
Acetylcysteine—Pruritus—Metformin—type 2 diabetes mellitus	0.000176	0.000922	CcSEcCtD
Acetylcysteine—Urticaria—Losartan—type 2 diabetes mellitus	0.000175	0.000919	CcSEcCtD
Acetylcysteine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000175	0.000915	CcSEcCtD
Acetylcysteine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000174	0.00091	CcSEcCtD
Acetylcysteine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000173	0.000906	CcSEcCtD
Acetylcysteine—Rash—Valsartan—type 2 diabetes mellitus	0.000172	0.000902	CcSEcCtD
Acetylcysteine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000172	0.000901	CcSEcCtD
Acetylcysteine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000172	0.000899	CcSEcCtD
Acetylcysteine—Rash—Orlistat—type 2 diabetes mellitus	0.00017	0.000891	CcSEcCtD
Acetylcysteine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00017	0.000891	CcSEcCtD
Acetylcysteine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000169	0.000885	CcSEcCtD
Acetylcysteine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000168	0.000882	CcSEcCtD
Acetylcysteine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000167	0.000873	CcSEcCtD
Acetylcysteine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000166	0.00087	CcSEcCtD
Acetylcysteine—Dizziness—Metformin—type 2 diabetes mellitus	0.000164	0.000862	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000164	0.000857	CcSEcCtD
Acetylcysteine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000163	0.000852	CcSEcCtD
Acetylcysteine—Nausea—Valsartan—type 2 diabetes mellitus	0.000162	0.00085	CcSEcCtD
Acetylcysteine—Nausea—Orlistat—type 2 diabetes mellitus	0.00016	0.00084	CcSEcCtD
Acetylcysteine—Vomiting—Metformin—type 2 diabetes mellitus	0.000158	0.000828	CcSEcCtD
Acetylcysteine—Rash—Metformin—type 2 diabetes mellitus	0.000157	0.000821	CcSEcCtD
Acetylcysteine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000157	0.000821	CcSEcCtD
Acetylcysteine—Pruritus—Losartan—type 2 diabetes mellitus	0.000156	0.000819	CcSEcCtD
Acetylcysteine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000155	0.000813	CcSEcCtD
Acetylcysteine—Urticaria—Ramipril—type 2 diabetes mellitus	0.00015	0.000788	CcSEcCtD
Acetylcysteine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00015	0.000784	CcSEcCtD
Acetylcysteine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000149	0.000782	CcSEcCtD
Acetylcysteine—Rash—Irbesartan—type 2 diabetes mellitus	0.000148	0.000775	CcSEcCtD
Acetylcysteine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000148	0.000774	CcSEcCtD
Acetylcysteine—Nausea—Metformin—type 2 diabetes mellitus	0.000148	0.000774	CcSEcCtD
Acetylcysteine—Dizziness—Losartan—type 2 diabetes mellitus	0.000146	0.000765	CcSEcCtD
Acetylcysteine—Vomiting—Losartan—type 2 diabetes mellitus	0.00014	0.000736	CcSEcCtD
Acetylcysteine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00014	0.000731	CcSEcCtD
Acetylcysteine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000139	0.00073	CcSEcCtD
Acetylcysteine—Rash—Losartan—type 2 diabetes mellitus	0.000139	0.00073	CcSEcCtD
Acetylcysteine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000139	0.000729	CcSEcCtD
Acetylcysteine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000134	0.000702	CcSEcCtD
Acetylcysteine—Nausea—Losartan—type 2 diabetes mellitus	0.000131	0.000687	CcSEcCtD
Acetylcysteine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000125	0.000656	CcSEcCtD
Acetylcysteine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00012	0.000631	CcSEcCtD
Acetylcysteine—Rash—Ramipril—type 2 diabetes mellitus	0.000119	0.000626	CcSEcCtD
Acetylcysteine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000119	0.000625	CcSEcCtD
Acetylcysteine—Nausea—Ramipril—type 2 diabetes mellitus	0.000113	0.000589	CcSEcCtD
Acetylcysteine—IKBKB—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.08e-05	6.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—type 2 diabetes mellitus	1.07e-05	6.05e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.07e-05	6.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.07e-05	6.03e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SNAP25—type 2 diabetes mellitus	1.07e-05	6.02e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PSMD6—type 2 diabetes mellitus	1.07e-05	6.02e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SREBF1—type 2 diabetes mellitus	1.07e-05	6.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.07e-05	6.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.07e-05	6.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD36—type 2 diabetes mellitus	1.07e-05	6.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—INSR—type 2 diabetes mellitus	1.06e-05	6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—type 2 diabetes mellitus	1.06e-05	5.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BCL2—type 2 diabetes mellitus	1.06e-05	5.95e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3R1—type 2 diabetes mellitus	1.05e-05	5.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PPP2CA—type 2 diabetes mellitus	1.05e-05	5.93e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CTGF—type 2 diabetes mellitus	1.05e-05	5.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.05e-05	5.89e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HMGCR—type 2 diabetes mellitus	1.04e-05	5.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.04e-05	5.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.04e-05	5.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—LPL—type 2 diabetes mellitus	1.04e-05	5.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.03e-05	5.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—RELA—type 2 diabetes mellitus	1.03e-05	5.82e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.03e-05	5.78e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.02e-05	5.75e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.02e-05	5.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.01e-05	5.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ADCY5—type 2 diabetes mellitus	1.01e-05	5.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.01e-05	5.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.01e-05	5.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—C3—type 2 diabetes mellitus	1.01e-05	5.69e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—type 2 diabetes mellitus	1.01e-05	5.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AGER—type 2 diabetes mellitus	9.99e-06	5.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.98e-06	5.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ADCY5—type 2 diabetes mellitus	9.96e-06	5.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.95e-06	5.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—RELA—type 2 diabetes mellitus	9.91e-06	5.58e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—type 2 diabetes mellitus	9.83e-06	5.54e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.78e-06	5.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—type 2 diabetes mellitus	9.74e-06	5.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—type 2 diabetes mellitus	9.74e-06	5.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PPP2CA—type 2 diabetes mellitus	9.71e-06	5.47e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC2A1—type 2 diabetes mellitus	9.67e-06	5.45e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1A2—type 2 diabetes mellitus	9.67e-06	5.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2L1—type 2 diabetes mellitus	9.67e-06	5.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.66e-06	5.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.66e-06	5.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD36—type 2 diabetes mellitus	9.66e-06	5.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRS2—type 2 diabetes mellitus	9.61e-06	5.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—type 2 diabetes mellitus	9.61e-06	5.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NFKB1—type 2 diabetes mellitus	9.6e-06	5.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—type 2 diabetes mellitus	9.58e-06	5.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PPP2CA—type 2 diabetes mellitus	9.54e-06	5.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CCR5—type 2 diabetes mellitus	9.54e-06	5.38e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CALM1—type 2 diabetes mellitus	9.43e-06	5.32e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP3A4—type 2 diabetes mellitus	9.43e-06	5.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.4e-06	5.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.4e-06	5.3e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	9.38e-06	5.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.36e-06	5.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—type 2 diabetes mellitus	9.32e-06	5.25e-05	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—type 2 diabetes mellitus	9.3e-06	5.24e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—SLC2A4—type 2 diabetes mellitus	9.27e-06	5.22e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GCG—type 2 diabetes mellitus	9.27e-06	5.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.24e-06	5.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GCG—type 2 diabetes mellitus	9.24e-06	5.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	9.22e-06	5.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.2e-06	5.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.16e-06	5.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.16e-06	5.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—C3—type 2 diabetes mellitus	9.16e-06	5.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.09e-06	5.12e-05	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—type 2 diabetes mellitus	9.07e-06	5.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.06e-06	5.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.05e-06	5.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SRC—type 2 diabetes mellitus	8.94e-06	5.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HIF1A—type 2 diabetes mellitus	8.89e-06	5.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IRS2—type 2 diabetes mellitus	8.87e-06	5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PRKCB—type 2 diabetes mellitus	8.87e-06	5e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—type 2 diabetes mellitus	8.84e-06	4.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ICAM1—type 2 diabetes mellitus	8.83e-06	4.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—type 2 diabetes mellitus	8.76e-06	4.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRS2—type 2 diabetes mellitus	8.71e-06	4.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—type 2 diabetes mellitus	8.71e-06	4.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CALM1—type 2 diabetes mellitus	8.71e-06	4.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NFKB1—type 2 diabetes mellitus	8.7e-06	4.9e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—type 2 diabetes mellitus	8.68e-06	4.89e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SRC—type 2 diabetes mellitus	8.59e-06	4.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOA1—type 2 diabetes mellitus	8.58e-06	4.84e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CALM1—type 2 diabetes mellitus	8.55e-06	4.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.52e-06	4.8e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IRS1—type 2 diabetes mellitus	8.39e-06	4.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.38e-06	4.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GCG—type 2 diabetes mellitus	8.38e-06	4.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	8.36e-06	4.71e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.24e-06	4.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.22e-06	4.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SRC—type 2 diabetes mellitus	8.11e-06	4.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS2—type 2 diabetes mellitus	8.09e-06	4.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.04e-06	4.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PRKCB—type 2 diabetes mellitus	8.04e-06	4.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ICAM1—type 2 diabetes mellitus	8.01e-06	4.51e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.99e-06	4.5e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	7.99e-06	4.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.96e-06	4.49e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	7.95e-06	4.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CASP8—type 2 diabetes mellitus	7.9e-06	4.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AVP—type 2 diabetes mellitus	7.86e-06	4.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.86e-06	4.43e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	7.85e-06	4.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—type 2 diabetes mellitus	7.84e-06	4.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.82e-06	4.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.79e-06	4.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SRC—type 2 diabetes mellitus	7.79e-06	4.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT2—type 2 diabetes mellitus	7.76e-06	4.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IRS1—type 2 diabetes mellitus	7.74e-06	4.36e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	7.62e-06	4.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRS1—type 2 diabetes mellitus	7.6e-06	4.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOB—type 2 diabetes mellitus	7.59e-06	4.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.56e-06	4.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—type 2 diabetes mellitus	7.53e-06	4.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.47e-06	4.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—INS—type 2 diabetes mellitus	7.41e-06	4.18e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	7.41e-06	4.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.29e-06	4.11e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	7.27e-06	4.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LPL—type 2 diabetes mellitus	7.25e-06	4.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.22e-06	4.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT2—type 2 diabetes mellitus	7.17e-06	4.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CASP8—type 2 diabetes mellitus	7.16e-06	4.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AVP—type 2 diabetes mellitus	7.12e-06	4.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.12e-06	4.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	7.12e-06	4.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—type 2 diabetes mellitus	7.11e-06	4.01e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.1e-06	4e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	7.1e-06	4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.09e-06	4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.06e-06	3.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3R1—type 2 diabetes mellitus	7.04e-06	3.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT2—type 2 diabetes mellitus	7.04e-06	3.97e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	6.91e-06	3.89e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—type 2 diabetes mellitus	6.9e-06	3.89e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOB—type 2 diabetes mellitus	6.89e-06	3.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.86e-06	3.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—type 2 diabetes mellitus	6.83e-06	3.85e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.82e-06	3.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SERPINE1—type 2 diabetes mellitus	6.81e-06	3.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.8e-06	3.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2—type 2 diabetes mellitus	6.78e-06	3.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.78e-06	3.82e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.68e-06	3.76e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—RELA—type 2 diabetes mellitus	6.63e-06	3.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LPL—type 2 diabetes mellitus	6.57e-06	3.71e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	6.55e-06	3.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—C3—type 2 diabetes mellitus	6.53e-06	3.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3R1—type 2 diabetes mellitus	6.5e-06	3.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS3—type 2 diabetes mellitus	6.5e-06	3.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.44e-06	3.63e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	6.42e-06	3.62e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3R1—type 2 diabetes mellitus	6.39e-06	3.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.23e-06	3.51e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	6.22e-06	3.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.21e-06	3.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AGT—type 2 diabetes mellitus	6.2e-06	3.5e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.17e-06	3.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2—type 2 diabetes mellitus	6.15e-06	3.46e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	6.12e-06	3.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.1e-06	3.44e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	6.1e-06	3.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LEP—type 2 diabetes mellitus	6.08e-06	3.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—type 2 diabetes mellitus	6.08e-06	3.43e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.06e-06	3.41e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	6.03e-06	3.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—type 2 diabetes mellitus	6.02e-06	3.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—RELA—type 2 diabetes mellitus	6.01e-06	3.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.01e-06	3.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—type 2 diabetes mellitus	5.95e-06	3.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—C3—type 2 diabetes mellitus	5.92e-06	3.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.73e-06	3.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.65e-06	3.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.63e-06	3.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AGT—type 2 diabetes mellitus	5.62e-06	3.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NFKB1—type 2 diabetes mellitus	5.59e-06	3.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—type 2 diabetes mellitus	5.56e-06	3.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.53e-06	3.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—type 2 diabetes mellitus	5.51e-06	3.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LEP—type 2 diabetes mellitus	5.51e-06	3.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—type 2 diabetes mellitus	5.46e-06	3.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.45e-06	3.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.42e-06	3.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—type 2 diabetes mellitus	5.34e-06	3.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	5.31e-06	2.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—type 2 diabetes mellitus	5.21e-06	2.94e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	5.21e-06	2.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.2e-06	2.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—INS—type 2 diabetes mellitus	5.19e-06	2.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.11e-06	2.88e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NFKB1—type 2 diabetes mellitus	5.07e-06	2.86e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—type 2 diabetes mellitus	5.04e-06	2.84e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.02e-06	2.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.02e-06	2.83e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.92e-06	2.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—type 2 diabetes mellitus	4.84e-06	2.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—type 2 diabetes mellitus	4.81e-06	2.71e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	4.77e-06	2.69e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.77e-06	2.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—type 2 diabetes mellitus	4.72e-06	2.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—INS—type 2 diabetes mellitus	4.71e-06	2.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.63e-06	2.61e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	4.57e-06	2.57e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.57e-06	2.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—type 2 diabetes mellitus	4.57e-06	2.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.55e-06	2.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.55e-06	2.57e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.55e-06	2.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.55e-06	2.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.32e-06	2.44e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—type 2 diabetes mellitus	4.3e-06	2.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RELA—type 2 diabetes mellitus	4.29e-06	2.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—type 2 diabetes mellitus	4.22e-06	2.38e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	4.18e-06	2.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—type 2 diabetes mellitus	4.14e-06	2.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.13e-06	2.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.13e-06	2.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RELA—type 2 diabetes mellitus	3.89e-06	2.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.87e-06	2.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.65e-06	2.06e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.61e-06	2.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—type 2 diabetes mellitus	3.51e-06	1.98e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.51e-06	1.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—type 2 diabetes mellitus	3.37e-06	1.9e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.31e-06	1.87e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.28e-06	1.85e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.28e-06	1.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—type 2 diabetes mellitus	3.24e-06	1.83e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—type 2 diabetes mellitus	3.24e-06	1.82e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—type 2 diabetes mellitus	3.18e-06	1.79e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—type 2 diabetes mellitus	3.05e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.01e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—type 2 diabetes mellitus	2.99e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.97e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.95e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—type 2 diabetes mellitus	2.94e-06	1.65e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.73e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.68e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—type 2 diabetes mellitus	2.27e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	2.1e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.09e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—type 2 diabetes mellitus	2.06e-06	1.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.9e-06	1.07e-05	CbGpPWpGaD
